P-1496

Known as: P 1496, P1496 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1973-1997
0119731997

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
We have previously examined, by alanine scanning mutagenesis, amino acids 515-535 of the estrogen receptor (ER) ligand binding… (More)
Is this relevant?
1986
1986
Nuclear interactions of alpha-zearalanol (P-1496) and oestradiol-17 beta (E2) were compared following binding of these compounds… (More)
Is this relevant?
1985
1985
It is now well established that the mycotoxin zearalenone and some of its derivatives possess oestrogenic activity. In the… (More)
Is this relevant?
1983
1983
Previous studies discovered a second class of estrogen-binding proteins distinct from estrogen receptor which exhibited higher… (More)
Is this relevant?
1982
1982
We have used a sensitive and quantitative assay to investigate the hormonal regulation of plasminogen activator (PA) activity in… (More)
Is this relevant?
1980
1980
The interference of two weak estrogens (P-1496 and P-1560) on the binding of estradiol with uterine estrogen receptors is… (More)
Is this relevant?
1977
1977
Treatment of postmenopausal women with a non-steroid oestrogen (P1496) in a dose of 50 mg a day for 2 ,days before operation for… (More)
Is this relevant?
1973
1973
The results are reported of a preliminary trial of P1496, a new non-steroidal oestrogen analogue, compared with a conjugated… (More)
  • table II
Is this relevant?